Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -165,614 | -129,492 | -106,806 | -14,172 | -9,827 |
| Depreciation Amortization | 46 | -275 | 216 | 803 | 305 |
| Accounts payable and accrued liabilities | 2,364 | 2,396 | -608 | 71 | 1,276 |
| Other Working Capital | 7,349 | 4,484 | 11,997 | 19,920 | 25,770 |
| Other Operating Activity | 121,288 | 111,717 | 87,633 | 3,269 | 981 |
| Operating Cash Flow | $-34,567 | $-11,170 | $-7,568 | $9,891 | $18,505 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -72,688 | N/A | -38,929 | N/A | N/A |
| PPE Investments | -4,508 | -2,164 | -831 | -482 | -446 |
| Net Acquisitions | N/A | N/A | 9,276 | N/A | N/A |
| Other Investing Activity | -41,723 | -35,067 | 0 | 0 | 0 |
| Investing Cash Flow | $-118,919 | $-37,231 | $-30,484 | $-482 | $-446 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 234,763 | 233,600 | 405 | 34 | 34 |
| Other Financing Activity | -14,624 | -14,155 | 116,003 | 60,875 | 0 |
| Financing Cash Flow | $220,139 | $219,445 | $116,408 | $60,909 | $34 |
| Beginning Cash Position | 98,779 | 98,779 | 20,423 | 20,423 | 20,423 |
| End Cash Position | 165,432 | 269,823 | 98,779 | 90,741 | 38,516 |
| Net Cash Flow | $66,653 | $171,044 | $78,356 | $70,318 | $18,093 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,567 | -11,170 | -7,568 | 9,891 | 18,505 |
| Capital Expenditure | -4,508 | -2,164 | -831 | -482 | -446 |
| Free Cash Flow | -39,075 | -13,334 | -8,399 | 9,409 | 18,059 |